Citations

Showing 10 of 108083 citations.

Targeting molecular and cellular inhibitory mechanisms for improvement in anti-tumor memory responses reactivated by tumor cell vaccine (50.17)
Dong, Haidong

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 178 | Issue: 1_Supplement | Pages: S93-S93

10.4049/jimmunol.178.supp.50.17 Get It

Abstract Development of effective vaccination approaches to treat established tumors represents a focus of intensive research because such approaches offer the promise of enhancing immune system priming against tumor antigens via re-stimulation of pre-existing (memory) antitumoral helper and effector immune cells. However, inhibitory mechanisms which function to limit the recall responses of tumor-specific immunity exist remain poorly understood and interfere with therapies anticipated to induce protective immunity. The mouse renal cell carcinoma (RENCA) tumor model was used to investigate variables affecting vaccination outcomes. We demonstrate that although a whole cell irradiated tumor cell vaccine can trigger a functional anti-tumor memory response in the bone marrows of mice with established tumors, these responses do not culminate in the regression of established tumors. In addition, a CD103+ regulatory T (Treg) cell subset accumulates within the draining lymph nodes of tumor-bearing mice. We also show that B7-H1 (CD274, PD-L1), a negative costimulatory ligand, and CD4+ Treg cells collaborate to impair the recall responses of tumor-specific memory T cells. Specifically, mice bearing large established RENCA tumors were treated with tumor cell vaccination in combination with B7-H1 blockade and CD4+ T cell depletion (triple therapy treatment) and monitored for tumor growth and survivability. Triple treatment therapy induced complete regression of large established RENCA tumors and raised long-lasting protective immunity. These results have implications for developing clinical antitumoral vaccination regimens in the setting where tumors express elevated levels of B7-H1 in the presence of abundant Treg cells.
HS1 and Itk cooperate to regulate actin remodeling and Ca2+ signaling in T cells (35.28)
Carrizosa, Esteban, Gomez, Timothy S., Labno, Christine M., Chang, Briana L., Dehring, Deborah A. Klos, Zhu, Peimin, Billadeau, Daniel D. , Chang, Briana L, Freedman, Bruce D. , Burkhardt, Janis K.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 182 | Issue: Supplement_1 | Pages: 35.28-35.28

10.4049/jimmunol.182.supp.35.28 Get It

Abstract Productive T cell activation requires efficient reorganization of the actin cytoskeleton. We have shown that the actin regulatory protein HS1 is required for the stabilization of F-actin and Vav1 at the immunological synapse (IS) and for efficient Ca2+ responses. The Tec family kinase Itk also regulates actin responses, in part by facilitating the localization of Vav1 at the IS, suggesting that these proteins act in the same pathway. Using video microscopy, we found that T cells lacking Itk or HS1 behaved similarly, extending unstable actin-rich protrusions upon TCR stimulation. HS1 and Itk could be coimmunoprecipitated from T cell lysates, and GST-pulldown studies showed that Itk’s SH2 domain binds directly to two phosphotyrosines in HS1. In the absence of Itk, HS1 failed to localize to the IS. Since Itk is required for PLCγ1 phosphorylation and Ca2+ store release, we examined the Ca2+ signaling pathway in HS1 knockout T cells in greater detail. T cells lacking HS1 exhibited abnormal Ca2+ store release. These cells showed normal phosphorylation but altered localization of PLCγ1. We conclude that Itk-dependent recruitment of HS1 is required for actin stabilization at the IS, and directs the localization of PLCγ1. Supported by NIH F31-AI071385 to EC and NIH R01-A1065644 to JKB
Biochemical evidence for bivalent T cell antigen receptor expression in primary T cells (35.42)
Turka, Laurence A. , Palmer, Ed, Schrum, Adam G.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 182 | Issue: Supplement_1 | Pages: 35.42-35.42

10.4049/jimmunol.182.supp.35.42 Get It

Abstract The αβ T cell antigen receptor (TCR)/CD3 complex is currently viewed as a monovalent receptor with the subunit composition αβγδε2ζ2. This model has emerged from among at least five different potential stoichiometries that were proposed in previous years. Recently, the case for the accepted stoichiometry has been supported by experiments involving co-immunoprecipitation (IP) followed by Western blot, and by blue native (BN)-PAGE. We have revisited the issue of TCR/CD3 stoichiometry by examining immunoprecipitated complexes by flow cytometry (IP-FCM), a technique which allows a quantitative estimate of the subunit constituents in native multi-protein complexes. Together with size-exclusion chromatography, the data supports the conventional stoichiometry, but provides evidence that the copy number may be two, making the TCR/CD3 a precisely bivalent complex, [αβγδε2ζ2] x 2. The expression of a bivalent TCR/CD3 complex has implications regarding possible mechanisms by which the interaction with antigen may trigger signaling. Research support: Adam G. Schrum, start-up funds from the Mayo Foundation; Laurence A. Turka, grants AI41521 and AI 43620 from NIH; Ed Palmer, grants from the Swiss National Science Foundation.
CD3 molecules in a conformational equilibrium that is altered by TCR engagement (35.41)
Gil, Diana , Kruger, Travis, Cruz, Javier de la

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 182 | Issue: Supplement_1 | Pages: 35.41-35.41

10.4049/jimmunol.182.supp.35.41 Get It

Abstract Previously we and others observed that the signaling module of the TCR, the CD3 complex, undergoes a conformational change at the level of its cytoplasmic tails when T cells are stimulated. At that time, we interpreted this data as proof that antigen recognition modifies the conformation of CD3 as part of the receptor triggering mechanism. In absence of specific structural information, the induced conformation has been referred to as "open CD3". Here we present new evidence that thymocytes display detectable amounts of "open CD3" even in the absence of antigenic stimulation. However, treatment of thymocytes with stimulatory anti-CD3 antibodies significantly increases the amount of "open CD3". We conclude that ligand binding causes many CD3 molecules to adopt the "open CD3" conformation. We propose that CD3 is expressed in an equilibrium between two distinguishable conformations, which may reflect "on" and "off" states that are perturbed by TCR engagement. The accumulation of a certain level of "open CD3" might trigger T cell activation. Research support: Diana Gil, Travis Kruger and Javier de la Cruz were supported with start-up funds from the Mayo Foundation.
TAP Association Influences the Conformation of Nascent MHC Class I Molecules
Owen, Barbara, Pease, Larry R. , Owen, Barbara A L

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 162 | Issue: 8 | Pages: 4677-4684

10.4049/jimmunol.162.8.4677 Get It

Abstract The influence of TAP-MHC class I interactions on peptide binding to the class I heavy chain is assessed during TAP-dependent assembly using Kb-specific Abs that recognize conformational changes induced by assembly with β2-microglobulin (β2m) and by peptide binding. A significant portion (45%) of Kb molecules in TAP+, RMA-derived microsomes are associated with the TAP complex as measured by coimmunoisolation of Kb using anti-TAP1 Abs, while only 20% of the Kb heavy chain molecules are isolated as Kbβ2m complexes with the α-Kb-specific Abs, Y-3 or K-10-56. The amount of Kb isolated with Y-3 and K-10-56 increases in proportion to transport and binding of peptide to the Kb molecules within the RMA microsomes. In contrast, less than 5% of the Kb within TAP2-RMA-S microsomes associated with the remaining TAP1 subunit. However, greater than 60% of Kb heavy chain is isolated as K-10-56- and Y-3-reactive Kbβ2m complexes. We propose that a TAP-MHC class I interaction serves to stabilize the MHC class I:β2m complex in an immature conformation (Y-3 and K-10-56 nonreactive) prior to high affinity peptide binding, preventing the export of class I molecules complexed with low affinity peptide ligands from the ER.
Degenerate Recognition of Alloantigenic Peptides on a Positive-Selecting Class I Molecule
Weaver, Arthur J., Pease, Larry R. , Tallquist, Michelle D.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 160 | Issue: 2 | Pages: 802-809

10.4049/jimmunol.160.2.802 Get It

Abstract The well-defined 2C T cell was used to investigate alloreactive degeneracy. A panel of class I molecules that are known ligands for the 2C TCR were sensitized with three known peptide ligands, p2Ca (LSPFPFDL), dEV-8 (EQYKFYSV), and SIYR-8 (SIYRYYGL). The peptide p2Ca was originally identified as the allopeptide seen in the Ld class I molecule by 2C T cells, 2C recognizes the dEV-8 peptide as the ligand in the Kbm3 class I molecule, and SIYR-8 was recently identified as a peptide ligand for 2C in the context of the Kb class I molecule. Strong recognition of all three Ag-presenting molecules occurred in the context of their respective allopeptides, but 2C recognized all three peptides to a measurable extent in the context of Kb. Molecular modeling of these Kb/peptide complexes revealed a high degree of similarity between dEV-8 and SIYR-8, but very little conformational similarity of either of these peptides with p2Ca. Furthermore, the structural changes in the mutant Kbm3 binding site resulted in generalized changes in the conformation of each of five bound peptides compared with those of the same peptides bound to Kb. The finding that degenerate recognition occurs on Kb, the restriction element responsible for selecting 2C T cells, suggests a unique relationship between a TCR and the Ag-presenting molecule that mediates its positive selection.
Anaphylactic Reactions and Concentrations of Antibody in Rats and Rabbits: Effect of Adrenalectomy and of Administration of Cortisone
Dews, Peter, Code, Charles F.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 70 | Issue: 3 | Pages: 199-206

10.4049/jimmunol.70.3.199 Get It

Summary and Conclusions The enhancing effect of adrenalectomy on anaphylaxis in rats has been confirmed. Part of this enhancement is caused by enhancement of the development of sensitivity by adrenalectomy which, however, does not appear to be due to an effect on concentrations of antibodies. Administration of cortisone, just prior to challenging, increased the resistance of adrenalectomized rats to anaphylactic shock although severe reactions still occurred. Administration of cortisone during sensitization of adrenalectomized rats reduced the development of sensitivity so that much milder anaphylactic reactions occurred. Intact of adrenalectomized rats that received injections of cortisone produced slightly lower concentrations of hemolysins when rabbit erythrocytes were injected than similarly treated rats that did not receive cortisone. Administration of cortisone to intact or adrenalectomized rabbits receiving daily intracutaneous injections of antigen lowered greatly the resulting concentrations of circulating antibodies and inhibited the development of cutaneous sensitivity. Adrenalectomy had some enhancing effect on cutaneous sensitivity. Administration of cortisone produced no detectable effect on the concentration of circulating hemolysins produced in guinea pigs after either subcutaneous or intravenous injection of rabbit erythrocytes.
Transforming growth factor beta induced PD-L1 expression promotes pro-fibrotic signaling
Leof, Edward B. , Jung, Mi-Yeon, Kang, Jeong Han

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 204 | Issue: 1_Supplement | Pages: 79.8-79.8

10.4049/jimmunol.204.supp.79.8 Get It

Abstract Immune checkpoint proteins such as programmed death-ligand 1 (PD-L1) retain general immune homeostasis and self-tolerance. PD-L1 binds to programmed cell death protein 1 (PD-1) and inhibits T cell activation or protects tumor cells from T cell-mediated killing. PD-L1 has recently been shown to be up-regulated in invasive lung fibroblasts by p53 and focal adhesion kinase (FAK), any potential role of transforming growth factor-beta (TGFβ) in PD-L1 action is unknown in fibrosis. TGFβ is a mysterious protein with various roles in healthy tissue homeostasis/development as well as the development or progression of cancer, fibrotic disorders, and immune modulation, et al. In the current study, we showed that TGFβ induces the expression of the immunoinhibitory molecule PD-L1 in human and murine fibroblasts in a Smad2/3- and YAP/TAZ-dependent manner. Furthermore, PD-L1 knockdown decreased the TGFβ-dependent induction of extracellular matrix proteins, including collagen Ia1 (colIa1) and alpha-smooth muscle actin (α-SMA), and cell migration/wound healing. In addition to an endogenous role for PD-L1 in profibrotic TGFβ signaling, TGFβ stimulated-human lung fibroblast-derived PD-L1 into extracellular vesicles (EVs) capable of inhibiting T-cell proliferation in response to T cell receptor stimulation and mediating fibroblast cell migration. These findings provide new insights and potential targets for a variety of fibrotic and malignant diseases.
Antigen presentation by CNS-resident microglia and macrophages is required for antiviral CD8 T cell responses in the brain following CNS viral challenge
Lipovsky, Chloe, Jin, Fang, Hansen, Michael J. , Johnson, Aaron J. , Goddery, Emma N. , Pavelko, Kevin D. , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 204 | Issue: 1_Supplement | Pages: 75.9-75.9

10.4049/jimmunol.204.supp.75.9 Get It

Abstract CD8 T cell responses are essential for clearance of infections and tumors in the central nervous system (CNS). Under homeostatic conditions, T cell access to the CNS parenchyma is restricted. An intricate process of T cell reactivation by antigen presenting cells (APCs) at CNS barriers is thought to allow activated antigen-specific T cells to infiltrate the parenchyma during neurological disease. The role of CNS-resident APCs during CD8 T cell infiltration of the CNS parenchyma is unclear. We hypothesized that microglia and brain-associated macrophages (BAMs) are APCs critical for antigen specific CD8 T cell reactivation and CNS infiltration. To test this hypothesis, we generated mice with tamoxifen-inducible deletion of MHC class I on microglia and BAMs by crossing CX3CR1creER mice with H-2Db fl/fl mice (Db cKO). We challenged these mice with intracranial infection of Theiler’s murine encephalomyelitis virus (TMEV), which generates a robust CD8 T cell response against a Db restricted antigen (VP2121–130) in the brain. At 7 days post infection (dpi), brain infiltrating Db:VP2-specific CD8 T cells were reduced in Db cKO mice compared to control, while peripheral priming of CD8 T cells was unaffected. Unexpectedly, inflammatory monocytes infiltrating the brain at 7 dpi were also reduced in Db cKO mice, indicating a role for microglia/BAMs and CD8 T cells in recruitment of inflammatory monocytes. Db cKO mice were able to clear virus, indicating functional antiviral responses against TMEV occur despite reduced immune infiltration. These results demonstrate that local antigen presentation by microglia and BAMs facilitates inflammatory monocyte recruitment and antigen-specific CD8 T cell responses in the brain after TMEV infection.
Homeostasis and transitional activation of regulatory T cells require c-Myc
Zeng, Hu, Chapman, Nicole M. , Saravia, Jordy , Dhungana, Yogesh , Wang, Yanyan, Raynor, Jana L. , Chi, Hongbo

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 204 | Issue: 1_Supplement | Pages: 78.3-78.3

10.4049/jimmunol.204.supp.78.3 Get It

Abstract Regulatory T (Treg) cell activation and expansion during neonatal life and in response to inflammation are critical for immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the oncogene and transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of Treg cell accumulation and functional activation. Myc activity is enriched in Treg cells generated during neonatal life and responding to inflammation. Myc-deficient Treg cells show cell-intrinsic defects in overall accumulation and ability to transition to an activated state during early life or acute inflammation. Consequently, loss of Myc in Treg cells results in a rapid, early-onset autoimmune disorder accompanied by uncontrolled effector CD4+ and CD8+ T cell responses. We also provide evidence that Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, Treg cell-specific deletion of Cox10, which is required for oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired Treg cell function and maturation. Thus, Myc coordinates Treg cell accumulation, transitional activation and metabolic programming to orchestrate immune homeostasis.